Literature DB >> 1871774

Comparison of three physiologically based pharmacokinetic models of benzene disposition.

F Y Bois1, T J Woodruff, R C Spear.   

Abstract

We assess the goodness of fit of three physiologically based models of benzene pharmacokinetics to experimental data in Fischer-344 rats. These models were independently developed and published. Large differences in the quality of the fit are observed. In addition, the parameter values leading to acceptable fits are spread over the entire range of physiologically plausible values and can be quite different from average or standard values. On the other hand, choosing standard values for the parameters does not ensure good predictions of all tissue levels. These results emphasize the difficulty of a rigorous calibration of physiological models, and the need for further research in this area, including precise experimental determination of parameter values. Physiological models are powerful tools, but for risk assessment purposes simpler models, making equivalent use of the crucial data, are probably preferable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871774     DOI: 10.1016/0041-008x(91)90291-l

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Model parameter estimation and analysis: understanding parametric structure.

Authors:  H Li; K Watanabe; D Auslander; R C Spear
Journal:  Ann Biomed Eng       Date:  1994 Jan-Feb       Impact factor: 3.934

3.  Breath measurements as volatile organic compound biomarkers.

Authors:  L Wallace; T Buckley; E Pellizzari; S Gordon
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

4.  Population toxicokinetics of benzene.

Authors:  F Y Bois; E T Jackson; K Pekari; M T Smith
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

Review 5.  Low-dose metabolism of benzene in humans: science and obfuscation.

Authors:  Stephen M Rappaport; Sungkyoon Kim; Reuben Thomas; Brent A Johnson; Frederic Y Bois; Lawrence L Kupper
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

6.  Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.

Authors:  Sven Björkman
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

7.  Benzene toxicokinetics in humans: exposure of bone marrow to metabolites.

Authors:  K H Watanabe; F Y Bois; J M Daisey; D M Auslander; R C Spear
Journal:  Occup Environ Med       Date:  1994-06       Impact factor: 4.402

8.  Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. I. Toluene and m-xylene.

Authors:  S Laparé; R Tardif; J Brodeur
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

9.  Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data.

Authors:  Karen H Watanabe; Mirjana V Djordjevic; Steven D Stellman; Patricia L Toccalino; Donald F Austin; James F Pankow
Journal:  Regul Toxicol Pharmacol       Date:  2009-06-18       Impact factor: 3.271

Review 10.  Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

Authors:  D Krewski; J R Withey; L F Ku; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.